Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy – a multicenter study from Polish Adult Leukemia Group

Key Points

• Elderly patients with acute myeloid leukemia showed low identification rates for intensive induction chemotherapy using comprehensive geriatric assessment.
• The study found that only 45% of suitable patients were accurately identified, highlighting a significant gap in current screening practices.
• Observational analysis conducted in multiple centers considered the complex needs of elderly patients, yet revealed poor alignment with chemotherapy eligibility.
• This calls for revised assessment strategies to improve suitable patient identification for chemotherapy in the elderly population.